TECARTUS
Google image searchProduct monograph
Active ingredient
brexucabtagene autoleucel, 200000000 CELLS/BAG
DIN: 02516667
Dosage form(s): SUSPENSION
Route(s) of administration: INTRAVENOUS
Schedule: Prescription / Schedule D
Company: GILEAD SCIENCES CANADA INC
Date: 16-DEC-2021
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01X — OTHER ANTINEOPLASTIC AGENTS (ATC, ATC/DDD)
- L01XL — Antineoplastic cell and gene therapy (ATC, ATC/DDD)
- L01XL06 — BREXUCABTAGENE AUTOLEUCEL (ATC/DDD)
